Xin Zhang

Xin Zhang

Auto-generated profile, based on publicly available information

Xin Zhang

Stony Brook University 1 Stony Brook, NY

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2026
Verified
Other
Open access
PDF file
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
MYC binds to the USP39 promoter.

2 October 2026
Verified
Other
Open access
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy primarily driven by oncogenic KRAS signaling. The splicing factor serine/arginine-rich splicing factor 1 (SRSF1) plays a key oncogenic role in PDAC through reciprocal cross-interactions with KRAS signaling. However, the mechanisms regulating SRSF1 protein stability remain poorly understood. In this study, we identify the deubiquitinase USP39 as a critical regulator of SRSF1 stability. It interacts with SRSF1 in an RNA-independent manner and suppresses its ubiquitination. USP39 is upregulated in PDAC and correlates with poor patient prognosis. Functional analyses demonstrate that USP39 promotes PDAC cell progression, in part through the stabilization of SRSF1. Mechanistically, MYC activates USP39 transcription through direct promoter binding. These findings define a MYC–USP39–SRSF1 regulatory axis that integrates transcriptional and posttranslational mechanisms in PDAC and suggest USP39 as a potential therapeutic target. Implications:USP39 functions as a central regulator that integrates transcriptional and posttranslational regulation in pancreatic cancer through the MYC–USP39–SRSF1 axis and represents a potential therapeutic target.

11 June 2026 in Molecular Cancer Research
Verified
Journal Article
Closed access
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy primarily driven by oncogenic KRAS signaling. The splicing factor SRSF1 plays a key oncogenic role in PDAC through reciprocal cross-interactions with KRAS signaling. However, the mechanisms regulating SRSF1 protein stability remain poorly understood. Here, we identify the deubiquitinase USP39 as a critical regulator of SRSF1 stability. It interacts with SRSF1 in an RNA-independent manner and suppresses its ubiquitination. USP39 is upregulated in PDAC and correlates with poor patient prognosis. Functional analyses demonstrate that USP39 promotes PDAC cell progression, in part through stabilization of SRSF1. Mechanistically, MYC activates USP39 transcription through direct promoter binding. These findings define a MYC–USP39–SRSF1 regulatory axis that integrates transcriptional and post-translational mechanisms in PDAC and suggest USP39 as a potential therapeutic target. Implications: USP39 functions as a central regulator that integrates transcriptional and post-translational regulation in pancreatic cancer through the MYC–USP39–SRSF1 axis and represents a potential therapeutic target.

2 October 2026
Verified
Other
Open access
PDF file
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
SRSF1 protein levels remain unchanged following knockdown of USP9X or USP10.

2 October 2026
Verified
Other
Open access
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
Table S1 from MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer

2 October 2026
Verified
Other
Open access
PDF file
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
USP39 knockdown decreases SRSF1 expression in subcutaneous xenografts.